News

Deal Announcements

Mersana Secures $4 Million Venture Debt Funding

Monday, October 27, 2008 5:36:00 AM PDT | VentureDeal Staff
Cambridge, Massachusetts -- Pharmaceutical company Mersana announced that it has received $4 million in a new round of venture debt financing.

Mersana (formerly Nanopharma Corp.) is developing oncology agents based on Fleximer, a material that enhances the strength and safety of drugs.

Fidelity BioSciences made the investment. The company did not disclose how it would use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1